Inhibitors of Angiogenesis and Blood Pressure

[1]  A. Danser,et al.  Mechanism of hypertension and proteinuria during angiogenesis inhibition: evolving role of endothelin-1 , 2013, Journal of hypertension.

[2]  J. Moslehi,et al.  Management of antiangiogenic therapy-induced hypertension. , 2012, Hypertension.

[3]  M. Copur,et al.  An algorithm for the management of hypertension in the setting of vascular endothelial growth factor signaling inhibition. , 2011, Clinical colorectal cancer.

[4]  C. Escalante,et al.  Vascular Endothelial Growth Factor Inhibitor-Induced Hypertension: Basics for Primary Care Providers , 2011, Cardiology research and practice.

[5]  B. Lévy,et al.  Effects of blood pressure control with perindopril/indapamide on the microcirculation in hypertensive patients. , 2010, American journal of hypertension.

[6]  D. Webb,et al.  Receptor tyrosine kinase inhibition, hypertension, and proteinuria: is endothelin the smoking gun? , 2010, Hypertension.

[7]  M. Maitland,et al.  Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors , 2010, Journal of the National Cancer Institute.

[8]  Eric Vicaut,et al.  Impaired Tissue Perfusion: A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus , 2008, Circulation.

[9]  H. Putter,et al.  Hypertension and Rarefaction during Treatment with Telatinib, a Small Molecule Angiogenesis Inhibitor , 2008, Clinical Cancer Research.

[10]  B. Lévy,et al.  Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  D. Rizzoni,et al.  Chapter 47 – The Effects of Hypertension on the Structure of Human Resistance Vessels , 2007 .

[12]  M. Safar,et al.  Increased skin capillary density in treated essential hypertensive patients. , 2006, American journal of hypertension.

[13]  R. Kreienberg,et al.  Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro , 2005, Angiogenesis.

[14]  E. Schiffrin.  Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. , 2004, American journal of hypertension.

[15]  A. Pries,et al.  Microcirculation in Hypertension: A New Target for Treatment? , 2001, Circulation.

[16]  P. Carmeliet.  Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[17]  N. Markandu,et al.  Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. , 1999, Hypertension.

[18]  N. Markandu,et al.  Structural skin capillary rarefaction in essential hypertension. , 1999, Hypertension.

[19]  M. Mulvany,et al.  Structure and function of small arteries. , 1990, Physiological reviews.

[20]  P. Tonellato,et al.  Microvascular rarefaction and tissue vascular resistance in hypertension. , 1989, The American journal of physiology.